Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2289332

Cl.Cl.NCC(=O)CN.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8387607 1.00
SCHEMBL1226620 0.91
Hydrochloric Acid SCHEMBL26693525 0.77
SCHEMBL6704842 0.75
Glycine SCHEMBL27532996 0.75 GLRA1 (0.83)
Glycine SCHEMBL28246391 0.75
Glycine SCHEMBL27256596 0.75 GLRA1 (0.83)
Acetone SCHEMBL10694002 0.74 GABRR1 (0.41)
Hydrochloric Acid SCHEMBL1195392 0.74
Hydrochloric Acid SCHEMBL9236457 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200930-A1 PROCESSES FOR PRODUCING POLYESTER LATEXES VIA SOLVENT-BASED AND SOLVENT-FREE EMULSIFICATION XEROX CORPORATION (US) 2011-08-18 US claimed
US-9201324-B2 Processes for producing polyester latexes via solvent-based and solvent-free emulsification XEROX CORPORATION (US) 2015-12-01 US disclosed
US-8865149-B2 Polymeric reagents comprising a ketone or a related functional group NEKTAR THERAPEUTICS (US) 2014-10-21 US disclosed
US-20110200930-A1 PROCESSES FOR PRODUCING POLYESTER LATEXES VIA SOLVENT-BASED AND SOLVENT-FREE EMULSIFICATION XEROX CORPORATION (US) 2011-08-18 US disclosed
US-7629400-B2 Image making medium HYMAN SYDNEY 2009-12-08 US disclosed
US-20070166277-A1 Polymeric reagents comprising a ketone or a related functional group NEKTAR THERAPEUTICS 2007-07-19 US disclosed
US-7208145-B2 Useful for providing conjugates with other substances NEKTAR THERAPEUTICS AL, CORPORATION (US) 2007-04-24 US disclosed
CN-1744918-A Polymeric reagents comprising a ketone or a related functional group NEKTAR THERAPEUTICS AL CORP (US) 2006-03-08 CN disclosed
EP-1581260-A2 POLYMERIC REAGENTS COMPRISING A KETONE OR A RELATED FUNCTIONAL GROUP Nektar Therapeutics Al, Corporation (US) 2005-10-05 EP disclosed
US-20050031576-A1 Water-soluble polymer segment and a functional group such as a ketone, a ketone hydrate, a thione, wherein the functional group is part of a cyclic structure attached to polymer segment through either a direct covalent bond or through one or more atoms; useful for forming polymer-active agent conjugates NEKTAR THERAPEUTICS 2005-02-10 US disclosed
WO-2004060406-A2 POLYMERIC REAGENTS COMPRISING A KETONE OR A RELATED FUNCTIONAL GROUP NEKTAR THERAPEUTICS AL, CORPORATION (US) 2004-07-22 WO disclosed
US-20030035917-A1 Image making medium HYMAN SYDNEY (US) 2003-02-20 US disclosed
US-5470856-A Tetrahydropyrimidine derivatives AKZO NOBEL N.V. (NL) 1995-11-28 US disclosed
EP-0559279-A1 Tetrahydropyrimidine derivatives Akzo Nobel N.V. (NL) 1993-09-08 EP disclosed